Agile Therapeutics reported 999K in Interest Expense on Debt for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Aceto ACET:US 50K 1000
Adma Biologics ADMA:US $ 3.3M 0.05M
Agile Therapeutics AGRX:US 999K 6K
Biomarin Pharmaceutical BMRN:US $ 3.87M 0.05M
JAZZ PHA JAZZ:US $ 93.47M 23.65M
Pacira Pharmaceuticals PCRX:US $ 7.33M 0.31M
Pfizer PFE:US $ 325M 9M
Teva Pharmaceutical Industries TEVA:US $ 232M 8M
Therapeuticsmd TXMD:US 7.52M 78K